Use of GLP-1s or glucose-dependent insulinotropic polypeptide agonists before upper endoscopy significantly increased the risk for residual gastric volume, according to data published in JAMA Internal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results